Medicare Enrolled

Dr. Carl Danzig, M.D.

Ophthalmology · Bonita Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
28901 TRAILS EDGE BLVD STE 202, Bonita Springs, FL 34134
2395443122
In practice since 2008 (17 years)
NPI: 1619137320 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Danzig from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Danzig? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Danzig

Dr. Carl Danzig is an ophthalmology in Bonita Springs, FL, with 17 years in practice. Based on federal Medicare data, Dr. Danzig performed 13,606 Medicare services across 3,887 unique beneficiaries.

Between the years covered by Open Payments, Dr. Danzig received a total of $328,599 from 32 pharmaceutical and/or device companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Danzig is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 10% volume in FL$ $328,599 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,606
Medicare services
Top 10% in FL for ophthalmology
3,887
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~800 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)6,060$29$58
Retinal imaging (OCT scan)2,265$30$100
Eye injection for retinal disease1,144$98$250
Eye exam, established patient, focused903$66$150
Retinal photography (fundus photo)884$27$120
Unclassified drugs765$73$214
Comprehensive eye exam, established patient761$88$450
Aflibercept eye injection (Eylea)344$696$1,750
Comprehensive eye exam, new patient119$98$450
Extended exam of the back part of the eye with optic nerve drawing119$11$80
Extended exam of the back part of the eye with retinal drawing71$18$80
Injection, ranibizumab, 0.1 mg58$186$690
Visual field test, extended35$50$100
Removal of eye fluid29$98$200
Exam of retinal blood vessels using a special camera after injection of a dye26$93$250
2d ultrasound scan of eye tissue and structures23$48$175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$328,599
Total received (2018-2024)
Avg $46,943/year across 7 years
Top 2% in FL for ophthalmology
32
Companies
358
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$160,894 (49.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159,206 (48.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,499 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$136,402
2023
$53,530
2022
$44,647
2021
$23,013
2020
$23,858
2019
$45,559
2018
$1,591

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$85,833
Astellas Pharma US Inc
$43,259
Ocular Therapeutix, Inc.
$38,808
Hoffmann-La Roche Limited
$38,583
Novartis Pharmaceuticals Corporation
$36,443
Genentech, Inc.
$35,124
Regeneron Healthcare Solutions, Inc.
$21,060
ABBVIE INC.
$12,811
F. Hoffmann-La Roche AG
$3,632
Alimera Sciences, Inc.
$2,265
Dutch Ophthalmic, USA
$2,250
Heidelberg Engineering, Inc.
$1,500
AbbVie Inc.
$1,296
ThromboGenics, Inc.
$1,250
Samsung Bioepis Co., Ltd.
$950
Regeneron Pharmaceuticals, Inc.
$879
Roche TCRC, Inc.
$709
NotalVision
$493
Allergan Inc.
$438
Apellis Pharmaceuticals, Inc.
$230
Aerie Pharmaceuticals, Inc.
$150
Allergan, Inc.
$111
Bausch & Lomb, a division of Bausch Health US, LLC
$103
Astellas US LLC
$95
Astellas Pharma Global Development
$86
EyePoint Pharmaceuticals US, Inc.
$58
Mallinckrodt Hospital Products Inc.
$51
Topcon Healthcare, Inc.
$50
Johnson & Johnson Surgical Vision, Inc.
$31
Eyevance Pharmaceuticals LLC
$20
Shire North American Group Inc
$17
Biogen, Inc.
$16
Top 3 companies account for 51.1% of total payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BUPARLISIB · COMBIGAN · DEXTENZA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · Flarex · ForeseeHome · ILUVIEN · Izervay · Jetrea · LUMIGAN · Lucentis · Non-Covered Product · OZURDEX · ReSure Sealant · Rhopressa · Rocklatan · SUSVIMO · Spectralis · Susvimo · Syfovre · Tecnis 1-piece IOL · VABYSMO · VUITY · Vabysmo · XIIDRA · YUTIQ · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (49%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for ophthalmology in FL.

Equivalent to $2,415 per 100 Medicare services performed
Looking for a ophthalmology in Bonita Springs?
Compare ophthalmologys in the Bonita Springs area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologys nearby

Geographic Context

Ophthalmologys within 10 mi
102
Per 100K population
12.9
County median income
$73,099
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
9.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Danzig is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (consulting-driven, top 2%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Danzig experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Danzig performed 6,060 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Danzig receive payments from pharmaceutical companies?
Yes. Dr. Danzig received a total of $328,599 from 32 companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Danzig's costs compare to other ophthalmologys in Bonita Springs?
Dr. Danzig's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Danzig) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →